"/> Novus Biologicals™ Peptide bloquant d’anticorps MA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps MAP3K12

Réf. : BL-RE-085488Réf. fabricant : 18264972 0.25 mg
356,36 € HT

Highly purified. Generating reliable and reproducible results.

Gene ID (Entrez)
7786
Espèces
Human
Pureté
>85%, by HPLC
Numéro d’adhésion
Q12852
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Marque
Novus Biologicals

Antigenic Blocking Peptide corresponding to amino acids 260 - 320 of human MAP3K12. The MAP3K12 Blocking Peptide is derived from Synthetic. The MAP3K12 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-085488
Réf. fabricant18264972
Gene ID (Entrez)7786
EspècesHuman
Pureté>85%, by HPLC
Numéro d’adhésionQ12852
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormuleSodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-46063. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDLKEC 2.7.11.25, Dual leucine zipper bearing kinase, EC 2.7.11, Leucine-zipper protein kinase, MAPK-upstream kinase, MEKK12, mitogen-activated protein kinase kinase kinase 12, Mixed lineage kinase, MUKdual leucine zipper kinase DLK, protein kinase MUK, ZPKleucine zipper protein kinase, ZPKP1
Symbole de gène(s)MAP3K12
Type de produitMAP3K12
Quantité0.25 mg
État réglementaireRUO - research use only
Une question, une configuration particulière ?
Contactez-nous pour un devis.